SUMMARY
INTRODUCTION
There is a continuum of sleep disordered breathing, from snoring to apnea. A large part of the population are affected, increasingly with age and overweight/obesity, and more frequently males (20%) than females (10 %) 1 . Although mostly studied in adults, respiratory sleep disorder also affects children (prevalence, 1% to 4%) 2 . Sleep disordered breathing consists in iterative partial or complete obstruction of the upper airway 3 . Definitions and diagnostic criteria have evolved over time, but are still founded on polysomnography (PSG) or respiratory polygraphy (RP) and the respiratory disturbance index (RDI). In epidemiology, these are seldom available, and studies have, so far, been mainly based on questionnaires and/or sleep diaries.
Several steps are needed to analyze genetic predisposition to a phenotypic trait, such as sleep disordered breathing, in humans. The first is to demonstrate a familial component: i.e., that certain families show abnormal numbers of cases. This is achieved by familial aggregation studies.
The second is to demonstrate a genetic component within this familial component. This is mainly achieved by twin studies. When the phenotype is a common one (as in the present case), genetic study uses genetic epidemiology, based on large samples (of families, of populations of several hundreds), using statistical methods, exploring for variations in markers or common genetic polymorphisms exerting moderate effects. The term here is "complex genetic predisposition" rather than Mendelian genetic predisposition, which identifiers genetic mutations or abnormalities that are generally rare but exert a strong deleterious effect, with an equally rare but severe phenotype (e.g., achondroplasia).
S. PLANCOULAINE
The study of complex genetic predisposition has progressed since the 1990s, with the development of typing methods (of genes or gene expression), which have become increasingly available, technologically, methodologically and financially (Fig. 1 ). For about 10 years, study of gene expression (messenger RNA (mRNA) measurement) and epigenetics (transcriptional modification without modification of DNA) or genome-wide association studies (GWAS) and/or direct whole-genome sequencing have been developing. Very recently, studies of networks or systems combining several such "omic" analyses have begun to be published. 6 . A total of 12,763 male and 3,037 female subjects were included from Swedish registries. Standardized incidence ratios were calculated, distinguishing men and women, and, overall, proved on average ratios to be increased by a factor of just over 3, regardless of gender.
FAMILIAL COMPONENT
They also found two peaks for age at diagnosis in male or female patients with familial history of OSAS compared to those without: at 30-34 and 60-64 years, both more pronounced in men than women. They found no correlation between spouses, suggesting little impact of adult environment. Given the origin of the data, no clinical details were available (notably, BMI).
These studies thus show familial aggregation of respiratory sleep disorder, involving several generations, including children.
Some also suggest an impact of facial development and BMI, although without explaining all of the cases described. Such familial aggregation may represent a shared environmental component and/or a genetic component.
oped from a single ovum), phenotypic concordance is due to shared genetic inheritance. In dizygotic twins, who developed from two separate ova, phenotypic concordance is due only to the half of the genotype they share. Presence of a genetic component is suggested when phenotypic concordance is stronger in mono-than di-zygotic twins.
In . They found 13% correlation between obesity and snoring, entirely attributable to shared genetic factors. They further estimated that only 30% of the genetic component in snoring could be attributed to genes also underlying obesity. Individual heritability of snoring was thus estimated at 23% (95% confidence interval (CI): 18%, 28%).
They thus suggested that snoring in elderly males has a familial basis with a genetic component that is largely independent of genes related to obesity 7 . Likewise, Desai et al., modeling a genetic effect as co-dominant with an environmental effect in their female twin pairs, estimated raw heritability of disturbing snoring at 52% (95% CI:36%, 68%), falling to 42% after adjustment on BMI, smoking and menopausal status 8 . Taken together, these studies demonstrate multigenerational familial aggregation of sleep disordered breathing, in different countries: i.e., in populations of differing origins (Caucasian, African American or Asian). They further demonstrated that this familial component was partly accounted for by genetic factors, and estimated heritability at 21% to 84% depending on population, phenotype (type of disorder studied) and associated factors such as BMI or morphology.
Historically, the first analyses of genetic predisposition were family studies: (i) familial segregation studies seeking to identify a so-called major gene with Mendelian transmission (dominant, co-dominant or recessive) within multigenerational families, or (ii) linkage studies seeking to locate a genetic effect, either on models derived from segregation analyses of multigenerational families or directly from data, usually concerning siblings, collected without preconception regarding the underlying genetic model of transmission.
ing) in the studied population versus the expected distribution according to various Mendelian models (dominant, co-dominant or recessive), taking account of known risk factors (gender, BMI, etc.), familial resemblance (parent-child, sib-sib, etc.) and the characteristics of the major gene being modeled (frequency of "at-risk" allele, and probability of being affected according to genotype: i.e., penetrance). These analyses are purely statistical and require no genetic typing. Two such studies have been published.
Holberg et al. studied snoring using a self-administered questionnaire between 1972 and 1996 in 584 families totaling 2,019 non-Hispanic Caucasian individuals aged 10 years and
FAMILY STUDIES
The principle consists in comparing the distribution of the observed phenotype (sleep disordered breath-
Segregation analyses
J Dentofacial Anom Orthod 2015;18:302 5 GENETICS OF SLEEP DISORDERED BREATHING (SYNDROMES EXCLUDED) over 9 . They focused on two phenomena: isolated snoring, and snoring associated with daytime somnolence as proxy for obstructive sleep apnea/ hypopnea syndrome (OSAHS). They also took account of gender, age and BMI as risk factors. In isolated snoring, they found a significant familial resemblance between mothers and children and between siblings but not between spouses who present no genetic heritage in common. They found no major gene effect, and suggested a polygenic effect with several genes involved, none of which predominated, and/or shared environmental effects. In OSAHS, they found significant resemblances between parents and daughters, especially as regards mothers, pointing to a major dominant or co-dominant gene (either being compatible) with residual familial correlations suggestive of other unidentified genetic and/ or environmental effects.
Buxbaum et al. studied 177 Caucasian families (1, 195 10 . They focused on AHI measured at home by RP, defined as at least 10 seconds' reduction in or arrest of airflow and at least 2.5% reduction in oxygen saturation. They found familial resemblance between 1 st degree relatives (parentchild, siblings) but not spouses, thus suggesting a genetic effect. In Caucasians, they found a recessive major gene after adjustment on age, explaining 28% of the variance. Adjustment on age and BMI eliminated the genetic effect in males, suggesting a major role of BMI. In African American families, they found a codominant major gene, accounting for 35% of variance; adjustment on BMI enhanced this genetic effect.
These two studies demonstrated genetic heterogeneity: several genes seem to be involved, some exerting a Mendelian effect (major genes), the genes and associated factors such as BMI varying according to population. Once a genetic model has been established, the major gene has to be located within the genome. This is achieved by genetic linkage analysis, using parameters estimated on segregation analysis. Linkage analysis involves typing genetic polymorphisms using dedicated or non-dedicated chips, and thus requires DNA from family members. One or more regions of the genome are then explored for genes which are transmitted within the family in the same way as the gene characterized by the parameters estimated on segregation analysis. Linkage is measured by LOD (logarithm of odds) score. No such studies have been published regarding snoring or OSAHS.
Another approach involves linkage analysis without presuppositions as to the genetic model underlying transmission. In the case of pairs of siblings, for example, for each polymorphism, the proportion of shared alleles that are identical by descent (IBD: identical to those of the parents) is compared to the proportion expected on Mendelian grounds (Fig. 2 [11] [12] [13] . They obtained genotyping data for 641 Caucasians (109 families) and 634 African Americans (128 families). They identified several regions with LOD scores suggesting linkage with AHI and/or OSAHS. In Caucasians, the main peaks for AHI were on chromosomes 6 and 10 in 6q23-25 and 10q24-q25, respectively. These two peaks, which diminish after adjustment for BMI, suggest a pleiotropic effect of these regions. Another promising region was in 6p11-q11, close to the orexin-2 receptor gene, suggesting passage via a cascade independent of BMI. In African Americans, the strongest links with AHI after adjustment on BMI were in 8p21.3, increasing after adjustment on BMI, and in 8q24.1, decreasing after adjustment on BMI. These analyses suggest that there are genetic regions related to sleep disordered breathing, acting both The family showed high prevalence of OSAHS and metabolic abnormalities: 46% of members (9 adults, 14 children) had OSAHS, severe in 5 cases (4 adults, 1 child). Moreover, at least two metabolic abnormalities (obesity, type-2 diabetes, hypertriglyceridemia, insulin resistance, or HDL or total cholesterol elevation) were found in 48% of the children. Linkage analysis found a significant peak in 19q13.4 for both OSAHS and HDL cholesterol level. Several candidate genes are present in this linkage region, including NK cell immunoglobulin receptor genes involved in modulating inflammatory response to cellular stress and to onset of atheroma.
The next step comprises casecontrol or association studies on candidate genes identified within the linkage regions. 
Based on shared parental alleles identical by descent (IBD) Expected distribution for pair of siblings
There is genetic linkage when there is an excess of IBD alleles shared by affected siblings 7 Case-control studies on probable candidate genes compare polymorphism frequency in candidate genes identified on linkage analysis or by prior knowledge found in the literature. To the best of our knowledge, no case-control studies have been published following the above-mentioned linkage studies. On the other hand, there have been several based on the literature, focusing on genes involved in inflammation and/or immunity [15] [16] [17] [18] [19] [20] [21] [22] , metabolism [15] [16] [17] [23] [24] [25] , cardiovascular disease [16] [17] [18] [26] [27] [28] , or neurological and sleep disorder 16, [19] [20] [21] [29] [30] [31] [32] . Figure 3 shows the overlap between some of these fields.
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CASE-CONTROL STUDIES
Figure 3 Main genes associated with sleep disorder breathing in case-control studies. In bold, genes replicated by different teams. #: results for both adults and children. In grey, associated factors taken into account or not according to the study.
For about the last 10 years, genotyping techniques and costs have greatly changed, allowing wholegenome case-control studies, known as Genome-Wide Association Studies: GWASs. In sleep disordered breathing, a consortium was set up to centralize data on Caucasians and African Americans: the CARe consortium. A dedicated chip, comprising genes targeting the heart, lungs, blood and sleep, was used, including slightly more than 45,000 polymorphisms. As the study included several populations from different cohorts, a metaanalysis approach was adopted. Two phenotypes were focused on: AHI ). For AHI, there were no significant findings (with p < 10 -6 ). However, the polymorphism with the smallest p-value lay on chromosome 9 in a non-coding region of the LPAR1 gene, which codes for a protein with a pro-inflammatory role promoting circulating monocytes 34 and also known to be associated with neurologic and craniofacial abnormalities in mice 35 . Regarding OSAHS, analysis revealed a significantly associated polymorphism on chromosome 1 in a non-coding region of PTGER3, with enhanced association after adjustment on BMI. PTGER3 codes for a protein modulating central and peripheral neurotransmitter release. It is also part of a haplotype (group of polymorphisms transmitted together) associated with onset of high blood pressure 36 . The polymorphism with the next lowest p-value was the one observed on chromosome 9 and associated with the AHI phenotype.
For African Americans, the main analysis concerned 647 individuals from the Cleveland cohort. Analysis found a significant association (p < 10 -6 ) between AHI and the chromosome 9 polymorphism in the noncoding region of LPAR1, enhanced in n on-obese subjects, and an almost significant association with a polymorphism in a non-coding region of ITPR2, the corresponding protein playing a role in intracellular calcium regulation and being implicated in inflammation, endothelial dysfunction and blood-pressure abnormalities 37 . There was also a significant negative association in non-obese subjects between OSAHS and a polymorphism lying close to the PLEK gene, coding for a protein involved in actin assembly within leukocytes and thus contributing to exocytosis. The third polymorphism identified, although non-significant, concerned the LPAR1 gene on chromosome 9.
The next step was to replicate these results in similar populations on a case-control study of candidate polymorphisms. Three were selected, but only two could be adequately typed (LPAR1 on chromosome 9, and PTGER3 on chromosome 1), in 1,795 Caucasians taken from the Western Australia Sleep Health Study (WASHS) and 1,010 African Americans taken from the Cleveland study (n = 459) and the Case Transdisciplinary Research in Energetics and Cancer Colon Polyps Study (CTRECCPS) (n = 551). These replication populations differed from the primary populations in terms of prevalence of OSAHS: the Caucasian population included more males (63% versus 47%) and obese subjects (mean BMI, 33 versus 29 kg/m 2 ), with a higher prevalence of OSAHS (77% versus 33%); the African American population was composed of two very different populations with female predominance (78% and 67%), one being a female OSAHS cohort with BMI of 41 versus 32 kg/m 2 (n = 459), and the other being a female cohort with BMI of 31 kg/m2, free of sleep disordered breathing (n = 551). The association between AHI and the PTGER3 polymorphism on chromosome 1 on a co-dominant model was GENETICS OF SLEEP DISORDERED BREATHING (SYNDROMES EXCLUDED) replicated in Caucasians, as well as the association between OSAHS and the LPAR1 polymorphism on chromosome 9 in African Americans. These two findings confirm that a complex genetic predisposition is involved in sleep disordered breathing. The two polymorphisms concern genes implicated in inflammation, raising the question of causality. Moreover, taking BMI into account seems to make little or no difference, suggesting that the effects are independent. Functional studies will be needed to establish the causal role of these polymorphisms and to understand the mechanisms involved, but have yet to be performed and/or published. also done by David Gozal's team 40 in a case-control study in 40 nonobese children aged 4-10 years, the 20 case subjects having OSAHS on PSG, with tonsillar hypertrophy. The chip, containing 44,000 transcripts (mRNA) covering the whole genome, identified 68 transcripts from white blood cells with differential (over or under) expression in cases. They were thus able to identify biological cascades or pathways, including 23 cellular and 32 functional processes, among which inflammatory response predominated. These methods open up complementary lines of research on the mechanisms underlying biological and organic abnormalities, but require molecular and functional confirmation.
Studies based on candidate gene transcription (with prior knowledge)
A recent functional study by David Gozal's team 18 included 605 children aged 5-10 years, with or without OSAHS, and concerned polymorphisms of a candidate gene, EDN1, coding for a protein involved in an intracellular signal implicated in vasoconstriction, left ventricle hypertrophy and asthma 38, 39 . It was recently shown that four EDN1 polymorphisms are frequent in children with OSAHS. The functional study showed that EDN1 expression, assessed by cell quantity of specific messenger RNA (mRNA), was higher in children with OSAHS than in those without (mean, 1.8 versus 1.65).
Studies based on genome-wide transcription (without prior knowledge)
Another approach is to explore whole-genome transcription, as was Gene expression may be altered without change in the genetic sequence itself. Several mechanisms have been identified that increase or decrease gene expression: (i) histone modification: histones are protein groups which chromosomal DNA curls around; modification may consist in acetylation, methylation, phosphorylation or ubiquitination; (ii) direct DNA methylation; or (ii) micro-mRNA fixing on DNA. DNA methylation has been most widely studied.
David Gozal's team performed a first case-control study in 5-10 yearolds matched for age, gender and ethnicity, with or without OSAHS on PSG 41 . They studied DNA methylation in a candidate gene (FOXP3) and its regulatory regions. The coded protein is involved in immune regulation 42 .
They demonstrated hypermethylation
Gene expression (messenger RNA) Epigenetics S. PLANCOULAINE in the FOXP3 promoter region, especially in case of CRP elevation, which is a marker for inflammation. They demonstrated hypermethylation of the eNOS promoter region in 4-12 year-olds with OSAHS associated with delayed post-occlusion response 43 , inducing significant reduction in mRNA expression as compared to children without response delay, proportionally to post-occlusion response time.
inflammation, respiratory control and pleiotropic effects. Networking was weighted by the number of genes and proteins included and their inter-relations. Data from public data-bases on protein-protein interactions and adipose tissue sequencing were then included, along with gene expression data (relative mRNA quantification) from a case-control study of postoperative subcutaneous and visceral adipose tissue from adult patients with or without OSAHS. Frequency scores were then calculated for each protein according to the networks they belong to, ranking them in decreasing order. The most frequent proteins, whatever the network, were those mainly involved in inflammation, some of which had already been associated with OSAHS (e.g., PDGF, EDN1, NOS3) or associated disorders (e.g., PI3K, STAT, MAPK, associated with insulin resistance, inflammation, etc.).
Information from several "omic" studies can be combined, allowing global network or system analysis, based on bioinformatics. One example is Liu et al.'s study 44 , in which a network was created from candidate genes and/or proteins identified in the literature, taking account of genes and/or proteins involved in craniofacial morphology, obesity,
Expression-based networks and systems
CONCLUSIONS/PERSPECTIVES
Research into the genetics of sleep disordered breathing is progressing. Results so far demonstrate a complex genetic predisposition and point to involvement of specific genes according to phenotype (e.g., AHI or OSAHS, or isolated or associated OSAHS), ethnicity, presence of overweight/obesity, etc. Even so, most genes playing a role in whatever context seem to be part of pro-inflammatory cascades. The reports require confirmation, by replication or functional or other studies. 
